Treatment Outcomes of Combination Therapy with 1,064-nm Neodymium-doped Yttrium Aluminum Garnet Laser and Efinaconazole 10% Solution for Big Toenail Onychomycosis: a Retrospective Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Laser therapy can be used as an alternative treatment for onychomycosis; however, there are some limitations to its efficacy as a single agent. Objective: To evaluate the effectiveness of combination therapy with 1,064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and topical efinaconazole in onychomycosis treatment and identify factors influencing the therapeutic outcomes of combination treatment. Methods: Big toenails with onychomycosis were treated by 1,064-nm Nd:YAG laser at 4-week intervals with daily application of topical efinaconazole. Therapeutic response was assessed through onychomycosis severity index (OSI) and percentage of nail infected (PNI), and its association with a variety of factors that may affect treatment outcome was evaluated. Results: One hundred big toenails were included in the study and significant clinical improvements were observed after treatment (OSI improvement score = 76.68 ± 28.83, PNI improvement score = 72.37 ± 30.37). There was no difference in treatment response according to the number of laser treatments, onychomycosis clinical type, or initial severity. However, patient age was negatively correlated with clinical improvement (p = 0.019). Also, female patients had better therapeutic responses than male patients. Conclusion: Combined treatment with Nd:YAG laser and topical efinaconazole has a significant therapeutic effect on onychomycosis. A randomized controlled trial is warranted in the future.
Abstract
Background: Laser therapy can be used as an alternative treatment for onychomycosis; however, there are some limitations to its efficacy as a single agent. Objective: To evaluate the effectiveness of combination therapy with 1,064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and topical efinaconazole in onychomycosis treatment and identify factors influencing the therapeutic outcomes of combination treatment. Methods: Big toenails with onychomycosis were treated by 1,064-nm Nd:YAG laser at 4-week intervals with daily application of topical efinaconazole. Therapeutic response was assessed through onychomycosis severity index (OSI) and percentage of nail infected (PNI), and its association with a variety of factors that may affect treatment outcome was evaluated. Results: One hundred big toenails were included in the study and significant clinical improvements were observed after treatment (OSI improvement score = 76.68 ± 28.83, PNI improvement score = 72.37 ± 30.37). There was no difference in treatment response according to the number of laser treatments, onychomycosis clinical type, or initial severity. However, patient age was negatively correlated with clinical improvement (p = 0.019). Also, female patients had better therapeutic responses than male patients. Conclusion: Combined treatment with Nd:YAG laser and topical efinaconazole has a significant therapeutic effect on onychomycosis. A randomized controlled trial is warranted in the future.
참고문헌 (18)
- 박진, "Korean Guideline for the Diagnosis and Treatment of Onychomycosis: Purpose and Process of Algorithm Guideline Development", 대한의진균학회지, 23(2), pp.33~44 (2018), 대한의진균학회[DOI]
- Kim TI, "A randomised comparative study of 1,064 nm Neodymiumdoped yttrium aluminum garnet (Nd:YAG) laser and topical antifungal treatment of onychomycosis", Mycoses, 59, pp.803~810 (2016)
- Gupta AK, "A retrospective chart review of the clinical efficacy of Nd:YAG 1,064-nm laser for toenail onychomycosis", J Dermatolog Treat, 26, pp.376~378 (2015)
- Wanitphakdeedecha R, "Efficacy and safety of 1,064-nm Nd:YAG laser in treatment of onychomycosis", J Dermatolog Treat, 27, pp.75~79 (2016)
- Kim MS, "The effectiveness of 1,064-nm long-pulsed Nd:YAG laser in the treatment of severe onychomycosis", J Cosmet Laser Ther, 18, pp.317~322 (2016)
- Karsai S, "Treating onychomycosis with the shortpulsed 1,064-nm-Nd:YAG laser: results of a prospective randomized controlled trial", J Eur Acad Dermatol Venereol, 31, pp.175~180 (2017)
- Gupta AK, "A critical review of improvement rates for laser therapy used to treat toenail onychomycosis", J Eur Acad Dermatol Venereol, 31, pp.1111~1118 (2017)
- Gupta AK, "Clinical trials of lasers for toenail onychomycosis: The implications of new regulatory guidance", J Dermatolog Treat, 28, pp.264~270 (2017)
- Ameen M, "British Association of Dermatologists' guidelines for the management of onychomycosis 2014", Br J Dermatol, 171, pp.937~958 (2014)
- Bonhert K, "Efficacy of combination therapy with efinaconazole 10% solution and 1,064 nm Nd:YAG laser for treatment of toenail onychomycosis", J Cosmet Laser Ther, 27, pp.1~5 (2018)
- 박귀영, "Randomized Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy with Short-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminium Garnet Laser and Amorolfine Nail Lacquer for Onychomycosis", Annals of Dermatology, 29(6), pp.699~705 (2017), 대한피부과학회
- Carney C, "A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index", Arch Dermatol, 147, pp.1277~1282 (2011)
- Kimura U, "Treating onychomycoses of the toenail: clinical efficacy of the sub-millisecond 1,064 nm Nd:YAG laser using a 5 mm spot diameter", J Drugs Dermatol, 11, pp.496~504 (2012)
- Shin MK, "Changes in nail keratin observed by Raman spectroscopy after Nd:YAG laser treatment", Microsc Res Tech, 80, pp.338~343 (2017)
- Pollak RA, "Long-term follow-up of onychomycosis patients treated with efinaconazole", J Drugs Dermatol, 16, pp.1269~1273 (2017)
- Elewski BE, "Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies", J Am Acad Dermatol, 68, pp.600~608 (2013)
- Xu Y, "Combined oral terbinafine and long-pulsed 1,064-nm Nd:YAG laser treatment is more effective for onychomycosis than either treatment alone", Dermatol Surg, 40, pp.1201~1207 (2014)
- El-Domyati M, "Nail changes and disorders in elderly Egyptians", J Cosmet Dermatol, 13, pp.269~276 (2014)